Xinjian Medical Secures Tens of Millions RMB in Series A Funding Led by Bilinxing Ventures to Advance Personalized 3D-Printed Orthopedic Solutions

Recently, VCBeat learned that Shanghai Xinjian Medical Technology Co., Ltd. announced that it had completed its Series A financing round in early 2018. This round of financing was led byProxima Ventures led the investment, with Dingxin Capital and Datai Capital participating as co-investors. Zhiyuan Capital served as the exclusive financial advisor for this round of financing.。

Xinjian Medical will utilize this financing,Prioritize the clinical application and intelligent advancement of medical 3D printing technology, improve the design and manufacturing of personalized implants, and accelerate the clinical certification of Class III implants.。

Xinjian Medical Technology Co., Ltd. was established in 2012 as a high-tech enterprise providing comprehensive 3D printing solutions for the medical industry, dedicated to delivering personalized and precise integrated solutions based on 3D printing technology. The company’s founding team possesses nearly two decades of experience in medical 3D printing, as well as in the research, development, and management of artificial implants. In the United States, they led and participated in the R&D and post-operative evaluation of novel artificial implants for several multinational medical device companies, including Zimmer Biomet and Medtronic. They were recipients of the “Hap Paul Award,” presented by the International Society for Technology in Arthroplasty on its 25th anniversary.

In an interview, the founder of Xinjian Medical stated that medical 3D printing technology will bring about a revolutionary transformation to the international orthopedic implant market, which is currently valued at up to $40 billion. Leveraging three-dimensional models derived from patients’ medical imaging and their clinical data, surgeries that were previously almost entirely dependent on physicians’ experience will be replaced by precise preoperative 3D planning, patient-specific surgical guides, and customized implants. This shift will enable personalized and precision orthopedic surgery, transforming currently unpredictable surgical outcomes into standardized, predictable procedures, significantly reducing surgical difficulty while enhancing accuracy, thereby optimizing clinical outcomes.

Mr. Sun Xiaolu, Partner at Bilin Capital, is highly optimistic about the market prospects of medical 3D printing technology. He stated that Xinjian Medical is a pioneer in the medical 3D printing industry, equipped with innovative professional products and a robust R&D team, enabling it to provide customized, comprehensive healthcare solutions for every patient. By leveraging 3D technology to accurately and efficiently print preoperative models, surgical guides, and personalized braces, the company facilitates precise preoperative surgical simulations, significantly enhancing diagnostic and treatment efficiency as well as postoperative outcomes. This approach holds substantial clinical significance and social value.

Currently, Xinjian Medical possesses independently developed medical 3D printing software systems and medical 3D printers at an internationally leading level, along with personalized medical services based on 3D printing. The company has completed the layout of more than 90 intellectual property rights, including invention patent applications in China and the United States, and has become one of the leading providers of comprehensive medical 3D printing solutions in China. Its collaborative clients include National Additive Manufacturing Innovation Center Co., Ltd., the 3D Printing Division of Aurora Group, and a number of top-tier Grade A tertiary hospitals in China.

During the interview, the founder of Xinjian Medical expressed sincere gratitude to the Zhiyuan team for their comprehensive services and support throughout the Series A financing process. He noted that the Zhiyuan team demonstrated profound insights into both the healthcare industry and the company’s operations. They worked closely with Xinjian Medical in refining the business model and consolidating fundraising materials, showcasing exceptional professionalism and dedication. The collaboration was highly pleasant, and he thanked them for their efficient service and conscientious approach.

It is reported that,Xinjian Medical secured tens of millions of RMB in angel financing from DT Capital Partners at its inception. DT Capital Partners’ additional investment in this round underscores its recognition of Xinjian Medical’s early-stage achievements and confidence in the company’s future market prospects.。